stockrow
Friday 6 November 2026
Export ICUI’s income statement to Excel — free account
ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
172.03
4.38
+2.61%
Follow ICUI
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
7,133.50 | 0.00 | 0.00 | 0.00 | 48.74 | 51.68 | 38.11 | 161.71 | 59.42 | 39.15 |
Piotroski F-Score |
6 | 5 | 6 | 1 | 7 | 4 | 4 | 5 | 5 | 7 |
P/S ratio |
1.58 | 1.59 | 1.08 | 1.67 | 3.82 | 3.53 | 3.05 | 3.35 | 3.28 | 6.27 |
Altman Z-Score |
2.12 | 2.10 | 1.63 | 1.86 | 13.53 | 12.33 | 9.35 | 10.74 | 10.42 | 34.95 |
P/FCF ratio |
38.68 | 33.03 | 33.06 | 0.00 | 26.97 | 34.89 | 0.00 | 63.98 | 56.71 | 34.66 |
Altman Z″-Score (non-manufacturers) |
2.90 | 2.91 | 2.73 | 2.52 | 11.32 | 10.60 | 8.86 | 8.33 | 8.30 | 23.67 |
Beneish M-Score |
(2.65) | (2.81) | (2.97) | (1.74) | (3.04) | (3.13) | (2.09) | (3.18) | (0.13) | (2.64) |
P/Operating CF |
58.01 | 94.16 | 26.81 | (2,229.31) | 60.92 | 57.11 | 79.00 | 93.79 | 50.13 | 112.08 |
P/B ratio |
1.66 | 1.93 | 1.15 | 1.83 | 3.11 | 2.99 | 2.80 | 3.71 | 3.54 | 3.61 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 3.64 | 3.53 | 3.40 | 4.18 | 4.07 | 3.76 |
EV/Sales |
2.01 | 2.12 | 1.69 | 2.30 | 3.43 | 3.25 | 2.85 | 3.13 | 3.10 | 5.10 |
EV/EBITDA |
17.99 | 18.79 | 14.79 | 23.28 | 21.10 | 22.38 | 19.51 | 41.74 | 75.12 | 18.72 |
EV/Operating CF |
24.98 | 24.79 | 22.99 | (84.58) | 16.86 | 18.52 | 35.36 | 27.31 | 25.99 | 21.51 |
EV/FCF |
49.42 | 44.15 | 51.62 | (32.75) | 24.18 | 32.10 | (881.26) | 59.78 | 53.70 | 28.18 |
Quick Ratio |
0.98 | 0.88 | 0.86 | 0.88 | 3.35 | 2.74 | 1.99 | 2.24 | 2.43 | 12.37 |
Current Ratio |
2.39 | 2.59 | 2.53 | 2.50 | 5.13 | 4.71 | 3.55 | 3.72 | 4.11 | 14.04 |
Net Debt/EBITDA |
3.91 | 4.73 | 5.32 | 6.38 | (2.44) | (1.95) | (1.39) | (3.64) | (5.62) | (4.31) |
Debt/Assets |
31.72% | 37.65% | 37.20% | 36.61% | 2.45% | 2.95% | 2.13% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.60 | 0.81 | 0.77 | 0.79 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.54 | 0.56 | 0.51 | 0.71 | 0.72 | 0.74 | 0.77 | 0.91 | 1.17 | 0.57 |
Operating CF/Net income |
245.69 | (1.73) | (5.60) | 0.84 | 2.59 | 2.56 | 1.01 | 5.56 | 2.25 | 1.43 |
Capex/Depreciation |
(0.43) | (0.40) | (0.39) | (0.37) | (0.89) | (1.09) | (1.37) | (1.16) | (1.19) | (1.04) |
Interest Coverage |
0.52 | 0.45 | 0.24 | (0.65) | (62.18) | (51.02) | 195.56 | 41.97 | (6.49) | 702.89 |
| 0.04% | (5.76%) | (1.41%) | (4.01%) | 6.61% | 6.03% | 7.65% | 2.34% | 7.39% | 10.17% | |
| 0.02% | (2.74%) | (0.67%) | (2.32%) | 5.66% | 5.03% | 6.16% | 1.87% | 6.24% | 9.48% | |
ROIC |
0.86% | 0.83% | 0.41% | (0.76%) | 7.04% | 5.37% | 5.99% | 2.11% | (0.93%) | 24.10% |
Return on Tangible Assets |
0.06% | (8.86%) | (2.19%) | (5.40%) | 7.95% | 7.29% | 9.27% | 2.59% | 6.52% | 10.27% |
Average Days of Receivables |
29.53 | 28.01 | 26.10 | 35.49 | 29.36 | 35.64 | 58.29 | 45.96 | 59.72 | 54.03 |
Research and Development Expense of Revenue |
3.92% | 3.72% | 3.78% | 4.08% | 3.61% | 3.38% | 3.84% | 3.78% | 3.97% | 3.41% |
Selling, General and Administrative Expense of Revenue |
28.02% | 26.82% | 26.86% | 26.68% | 22.99% | 22.34% | 21.87% | 22.86% | 23.38% | 23.57% |
Intangible Assets out of Total Assets |
0.53 | 0.52 | 0.54 | 0.54 | 0.12 | 0.13 | 0.14 | 0.09 | 0.10 | 0.04 |
Share Based Compensation of Revenue |
2.50% | 1.97% | 1.80% | 1.58% | 2.08% | 1.88% | 1.73% | 1.73% | 1.50% | 4.02% |
Graham Net Nets |
(0.21) | (0.21) | (0.42) | (0.31) | 0.15 | 0.15 | 0.15 | 0.13 | 0.13 | 0.22 |
Graham Number |
6.23 | 0.00 | 0.00 | 0.00 | 91.38 | 81.91 | 85.88 | 44.49 | 70.70 | 58.77 |
Earnings Yield |
0.01% | (3.11%) | (1.21%) | (1.95%) | 2.05% | 1.93% | 2.62% | 0.62% | 1.68% | 2.55% |
Free Cash Flow Yield |
2.59% | 3.03% | 3.03% | (4.21%) | 3.71% | 2.87% | (0.11%) | 1.56% | 1.76% | 2.88% |
Revenue per Share |
90.55 | 97.67 | 93.77 | 95.53 | 62.07 | 60.79 | 61.38 | 68.65 | 65.90 | 23.46 |
Operating CF per Share |
7.30 | 8.37 | 6.90 | (2.60) | 12.62 | 10.65 | 4.94 | 7.86 | 7.87 | 5.56 |
Capex per Share |
(3.61) | (3.67) | (3.83) | (4.12) | (3.82) | (4.51) | (5.14) | (4.27) | (4.06) | (1.32) |
Free Cash Flow per Share |
3.69 | 4.70 | 3.07 | (6.72) | 8.80 | 6.15 | (0.20) | 3.59 | 3.81 | 4.25 |
Cash per Share |
12.50 | 12.65 | 10.57 | 8.92 | 26.75 | 19.65 | 14.19 | 18.74 | 15.30 | 27.53 |
Shareholders Equity per Share |
86.19 | 80.58 | 88.14 | 87.56 | 76.21 | 71.85 | 66.76 | 61.96 | 61.09 | 40.83 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
86.19 | 80.58 | 88.14 | 87.56 | 76.21 | 71.85 | 66.76 | 61.96 | 61.09 | 40.83 |
Free Cash Flow |
90.89 | 114.57 | 74.03 | (160.47) | 186.59 | 128.54 | (4.09) | 73.20 | 74.74 | 68.66 |
Working Capital |
691.69 | 885.80 | 739.43 | 740.64 | 829.03 | 725.29 | 633.73 | 677.75 | 654.37 | 528.56 |
Capital Expenditures |
(88.96) | (89.46) | (92.17) | (98.34) | (80.95) | (94.21) | (106.01) | (87.01) | (79.68) | (21.28) |
Net Current Asset Value |
(736.13) | (796.71) | (1,033.76) | (1,190.52) | 765.11 | 659.35 | 567.06 | 605.30 | 565.97 | 524.56 |
EV/EBIT |
104.88 | 117.74 | 167.41 | 0.00 | 36.61 | 42.03 | 33.56 | 147.06 | 0.00 | 23.33 |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 | 0.06 | 0.07 | 0.08 | 0.06 | 0.06 | 0.06 |
Price to Operating Income |
82.08 | 88.08 | 107.21 | 0.00 | 40.84 | 45.68 | 35.95 | 157.38 | 0.00 | 28.69 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.46 | 0.51 | 0.38 | 0.42 | 0.19 | 0.18 | 0.17 | 0.17 | 0.17 | 0.24 |
Cash ROIC |
2.45% | 2.97% | 1.85% | (4.06%) | 8.37% | 6.54% | (0.24%) | 4.45% | 4.99% | 6.21% |
Accounts Receivable Turnover |
12.28 | 13.83 | 11.79 | 13.92 | 11.45 | 7.79 | 6.69 | 7.22 | 9.66 | 6.66 |
Accounts Payable Turnover |
9.32 | 10.45 | 8.30 | 10.65 | 10.78 | 8.08 | 6.38 | 8.35 | 18.66 | 12.57 |
Inventory Turnover |
2.35 | 2.41 | 2.16 | 3.21 | 2.73 | 2.48 | 2.45 | 2.77 | 5.13 | 3.83 |
Average Days of Payables |
39.98 | 34.69 | 36.04 | 49.81 | 35.90 | 32.40 | 59.10 | 52.98 | 32.95 | 30.03 |
Days of Inventory on Hand |
159.51 | 137.04 | 170.42 | 160.56 | 128.44 | 142.00 | 155.15 | 136.83 | 121.59 | 101.03 |
Average Receivables |
181.67 | 172.20 | 191.64 | 163.81 | 114.99 | 163.16 | 189.26 | 193.90 | 133.83 | 57.00 |
Average Payables |
151.20 | 149.03 | 182.97 | 148.52 | 76.50 | 100.25 | 124.55 | 99.35 | 46.43 | 14.16 |
Average Inventory |
600.27 | 647.02 | 702.68 | 493.12 | 302.58 | 326.28 | 324.40 | 299.91 | 168.96 | 46.45 |
Average Assets |
4,127.22 | 4,291.19 | 4,447.04 | 3,198.19 | 1,822.21 | 1,728.04 | 1,638.89 | 1,541.17 | 1,100.82 | 665.76 |
Average Common Equity |
2,044.53 | 2,044.32 | 2,106.67 | 1,852.98 | 1,559.15 | 1,439.75 | 1,320.45 | 1,230.95 | 929.20 | 620.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026